Analytical Chemistry p. 2301 - 2305 (1991)
Update date:2022-08-11
Topics:
Kishida, Mari
Makita, Yuji
Suzuki, Takehiko
Yamada, Masaaki
Hobo, Toshiyuki
A novel chemiluminescence system is described for the flow injection determination of phenylpyruvic acid (PPA). The presence of both ordered surfactant molecular assemblies and a metal ion catalyst in the system is essential for the phosphorescence of benzaldehyde (emitter) produced by the aerobic oxidation of PPA in alkaline solution. Dioctadecyldimethylammonium chloride bilayer aggregates and cobalt(II) allows PPA to be selectively determined down to 1 × 10-7 M. The linearity is 2 orders of magnitude with a relative standard deviation 3.1% (n = 10) for 1 × 10-6 M PPA. Of 28 other species (1 × 10-3 M) tested, only 4-hydroxymanderic acid, 4-hydroxyphenylpyruvic acid, 2,5-dlhydroxyphenylacetic acid, and 4-hydroxy-3-methoxyphenylpyruvic acid provided signals 2-13 times more intense than that for 1 × 10-6 M PPA. PPA present at 10-3-10-2 M levels in urine from patients with phenylketonuria can be determined with no special sample pretreatment by using this CL procedure. The mechanistic study of the present luminescent reaction are also undertaken in detail. The bilayer aggregates were found to contribute favorably both to the production of key intermediates and to the efficient phosphorescence emission.
View MoreWinchem Industrial Co. Ltd.(expird)
Contact:86-574-83851061 86-574-87083208
Address:Room 905, No.3 Building,East Business Center, 456 Xingning Road, Ningbo City,China
Jinzhou Jiutai Pharmaceutical Co.,Ltd
Contact:+86-0416-5179890
Address:No.41, Taianli, Taihe District, Jinzhou, Liaoning
jiangsu haian chemical co.,ltd.
Contact:86-513-15851283853
Address:No.99,Changjiang West Road,Haian County,Jiangsu Province,China
Shanghai Rainbow Chemistry Co., Ltd.
Contact:+86-21-64968086-5815/5812
Address:3rd floor, Building 7, 251 Faladi Road, Zhangjiang Hi-Tech Park, Pudong District, Shanghai, P.R. China
FUJIAN SHANSHUI CHEMICAL CORP.LTD.
Contact:+86-151-59920036
Address:Jinqiao Gareden, jo@fj-xinyi.com
Doi:10.1016/j.ijpharm.2018.10.072
(2019)Doi:10.1021/jo970876x
(1997)Doi:10.1039/jr9530003869
(1953)Doi:10.1039/C39720001125
(1972)Doi:10.1039/c9ob00716d
(2019)Doi:10.1021/jo00958a025
(1973)